 Kristen DeSanto
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myofascial Pain Syndromes | 2 | 2023 | 12 | 1.580 |
Why?
| | Acupuncture Therapy | 2 | 2023 | 22 | 1.570 |
Why?
| | Low Back Pain | 2 | 2023 | 108 | 1.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 348 | 1.070 |
Why?
| | Patient Education as Topic | 2 | 2022 | 779 | 0.900 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2023 | 4 | 0.840 |
Why?
| | Nutrition Therapy | 1 | 2023 | 35 | 0.810 |
Why?
| | Fibromyalgia | 1 | 2023 | 53 | 0.790 |
Why?
| | Naltrexone | 1 | 2023 | 102 | 0.750 |
Why?
| | Postmenopause | 1 | 2023 | 371 | 0.690 |
Why?
| | Water Sports | 1 | 2020 | 3 | 0.670 |
Why?
| | Anti-Asthmatic Agents | 1 | 2023 | 273 | 0.670 |
Why?
| | Hallucinogens | 1 | 2022 | 112 | 0.650 |
Why?
| | Antipsychotic Agents | 1 | 2022 | 212 | 0.640 |
Why?
| | Analgesics | 2 | 2022 | 226 | 0.640 |
Why?
| | Ganglion Cysts | 1 | 2020 | 10 | 0.630 |
Why?
| | Wound Healing | 1 | 2022 | 350 | 0.630 |
Why?
| | Behavior Therapy | 1 | 2022 | 282 | 0.610 |
Why?
| | Wrist | 1 | 2020 | 58 | 0.600 |
Why?
| | Spironolactone | 1 | 2019 | 34 | 0.600 |
Why?
| | Diuretics | 1 | 2019 | 73 | 0.600 |
Why?
| | Memory | 1 | 2021 | 263 | 0.590 |
Why?
| | Clostridium Infections | 1 | 2019 | 74 | 0.560 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 109 | 0.560 |
Why?
| | Glycemic Index | 1 | 2018 | 26 | 0.560 |
Why?
| | Viscosupplements | 1 | 2018 | 11 | 0.560 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 117 | 0.550 |
Why?
| | Communication | 3 | 2021 | 951 | 0.540 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 412 | 0.540 |
Why?
| | Musculoskeletal System | 1 | 2018 | 49 | 0.540 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2537 | 0.530 |
Why?
| | Testosterone | 1 | 2021 | 405 | 0.520 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 176 | 0.510 |
Why?
| | Humans | 50 | 2024 | 141754 | 0.500 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 244 | 0.500 |
Why?
| | Chagas Disease | 3 | 2021 | 44 | 0.480 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2024 | 1634 | 0.470 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 230 | 0.470 |
Why?
| | Cannabis | 1 | 2022 | 513 | 0.450 |
Why?
| | Sleep | 1 | 2022 | 885 | 0.450 |
Why?
| | Pain Measurement | 3 | 2023 | 554 | 0.450 |
Why?
| | Osteoarthritis, Knee | 1 | 2018 | 272 | 0.430 |
Why?
| | Athletic Injuries | 1 | 2020 | 525 | 0.420 |
Why?
| | Glucocorticoids | 1 | 2018 | 534 | 0.400 |
Why?
| | Skin Neoplasms | 1 | 2020 | 857 | 0.390 |
Why?
| | Upper Extremity | 2 | 2024 | 109 | 0.350 |
Why?
| | Health Promotion | 1 | 2018 | 759 | 0.350 |
Why?
| | Hormone Replacement Therapy | 2 | 2023 | 102 | 0.340 |
Why?
| | Asthma | 1 | 2023 | 1920 | 0.340 |
Why?
| | Hypertension | 1 | 2019 | 1254 | 0.330 |
Why?
| | Palliative Care | 4 | 2024 | 822 | 0.320 |
Why?
| | Cardiomyopathies | 2 | 2021 | 331 | 0.260 |
Why?
| | Pain Management | 2 | 2023 | 396 | 0.260 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2096 | 0.250 |
Why?
| | Advance Care Planning | 2 | 2021 | 223 | 0.250 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 581 | 0.240 |
Why?
| | Sepsis | 2 | 2022 | 621 | 0.230 |
Why?
| | Peripheral Nerve Injuries | 1 | 2024 | 38 | 0.220 |
Why?
| | Population Groups | 2 | 2021 | 58 | 0.210 |
Why?
| | Parental Leave | 1 | 2024 | 27 | 0.210 |
Why?
| | Milk Hypersensitivity | 1 | 2024 | 19 | 0.210 |
Why?
| | Egg Hypersensitivity | 1 | 2024 | 32 | 0.210 |
Why?
| | Muscle Cramp | 1 | 2023 | 7 | 0.210 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2024 | 53 | 0.210 |
Why?
| | Live Birth | 1 | 2024 | 68 | 0.210 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 13 | 0.210 |
Why?
| | Amitriptyline | 1 | 2023 | 22 | 0.210 |
Why?
| | Preconception Care | 1 | 2024 | 48 | 0.200 |
Why?
| | Trigger Points | 1 | 2023 | 13 | 0.200 |
Why?
| | Desensitization, Immunologic | 1 | 2024 | 95 | 0.200 |
Why?
| | Magnesium | 1 | 2023 | 158 | 0.200 |
Why?
| | Urogenital Abnormalities | 1 | 2023 | 71 | 0.190 |
Why?
| | Stroke | 2 | 2022 | 1158 | 0.190 |
Why?
| | Fertility | 1 | 2024 | 165 | 0.190 |
Why?
| | Quetiapine Fumarate | 1 | 2022 | 24 | 0.190 |
Why?
| | Aripiprazole | 1 | 2022 | 21 | 0.190 |
Why?
| | Job Satisfaction | 1 | 2024 | 224 | 0.190 |
Why?
| | Rectum | 1 | 2023 | 192 | 0.180 |
Why?
| | Administration, Inhalation | 1 | 2023 | 594 | 0.180 |
Why?
| | Transition to Adult Care | 1 | 2023 | 92 | 0.180 |
Why?
| | Leg | 1 | 2023 | 236 | 0.180 |
Why?
| | Chagas Cardiomyopathy | 1 | 2021 | 24 | 0.180 |
Why?
| | Insulin, Isophane | 1 | 2021 | 21 | 0.170 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1570 | 0.170 |
Why?
| | Benzodiazepines | 1 | 2022 | 162 | 0.170 |
Why?
| | Back Injuries | 1 | 2020 | 6 | 0.170 |
Why?
| | Wounds, Gunshot | 1 | 2024 | 248 | 0.170 |
Why?
| | Colon | 1 | 2023 | 300 | 0.170 |
Why?
| | Drowning | 1 | 2020 | 6 | 0.170 |
Why?
| | Dermoscopy | 1 | 2020 | 11 | 0.170 |
Why?
| | Aged, 80 and over | 5 | 2021 | 7923 | 0.170 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 1041 | 0.170 |
Why?
| | Insulin Glargine | 1 | 2021 | 84 | 0.170 |
Why?
| | Facial Injuries | 1 | 2020 | 23 | 0.170 |
Why?
| | Neck Injuries | 1 | 2020 | 20 | 0.160 |
Why?
| | Torso | 1 | 2020 | 34 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1250 | 0.160 |
Why?
| | Attitude to Computers | 1 | 2020 | 29 | 0.160 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 501 | 0.160 |
Why?
| | Health Information Exchange | 1 | 2020 | 24 | 0.160 |
Why?
| | Patient Selection | 1 | 2024 | 688 | 0.160 |
Why?
| | Ambulances | 1 | 2020 | 52 | 0.160 |
Why?
| | Bone and Bones | 1 | 2022 | 317 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 526 | 0.160 |
Why?
| | Nurse's Role | 1 | 2021 | 167 | 0.150 |
Why?
| | Pelvis | 1 | 2020 | 115 | 0.150 |
Why?
| | Transgender Persons | 1 | 2023 | 200 | 0.150 |
Why?
| | Intrauterine Devices | 1 | 2019 | 29 | 0.150 |
Why?
| | Dietary Supplements | 1 | 2023 | 570 | 0.150 |
Why?
| | Wearable Electronic Devices | 1 | 2020 | 55 | 0.150 |
Why?
| | Shock, Septic | 1 | 2021 | 210 | 0.150 |
Why?
| | Teaching | 1 | 2021 | 237 | 0.150 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 234 | 0.150 |
Why?
| | Patient Readmission | 1 | 2024 | 708 | 0.150 |
Why?
| | Colonoscopy | 1 | 2021 | 251 | 0.150 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 170 | 0.140 |
Why?
| | Long-Term Care | 1 | 2019 | 110 | 0.140 |
Why?
| | Weight Loss | 1 | 2024 | 791 | 0.140 |
Why?
| | Volunteers | 1 | 2018 | 40 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 35 | 0.140 |
Why?
| | Injections, Intra-Articular | 1 | 2018 | 59 | 0.140 |
Why?
| | Pain | 1 | 2023 | 781 | 0.140 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 179 | 0.140 |
Why?
| | Burnout, Professional | 1 | 2024 | 459 | 0.140 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 184 | 0.130 |
Why?
| | Cytokines | 2 | 2022 | 2100 | 0.130 |
Why?
| | Female | 13 | 2024 | 75943 | 0.130 |
Why?
| | Terminal Care | 1 | 2021 | 252 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 771 | 0.130 |
Why?
| | Cooperative Behavior | 1 | 2020 | 463 | 0.130 |
Why?
| | Library Services | 1 | 2016 | 8 | 0.130 |
Why?
| | Libraries, Medical | 1 | 2016 | 12 | 0.130 |
Why?
| | Antigens, Fungal | 1 | 2016 | 27 | 0.130 |
Why?
| | Cryptococcus | 1 | 2016 | 15 | 0.120 |
Why?
| | Recurrence | 1 | 2020 | 1111 | 0.120 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 444 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 439 | 0.120 |
Why?
| | Meningitis, Cryptococcal | 1 | 2016 | 33 | 0.120 |
Why?
| | Hypoglycemia | 1 | 2021 | 468 | 0.120 |
Why?
| | Vomiting | 1 | 2016 | 129 | 0.120 |
Why?
| | Hospice Care | 1 | 2019 | 205 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 1048 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1320 | 0.120 |
Why?
| | Prevalence | 2 | 2021 | 2799 | 0.120 |
Why?
| | Skin | 1 | 2020 | 765 | 0.120 |
Why?
| | Administration, Oral | 1 | 2018 | 803 | 0.120 |
Why?
| | Perception | 1 | 2018 | 378 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2022 | 650 | 0.110 |
Why?
| | Aged | 6 | 2024 | 24746 | 0.110 |
Why?
| | Acute Disease | 1 | 2018 | 1010 | 0.110 |
Why?
| | Ultrasonography | 1 | 2019 | 761 | 0.110 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 750 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2064 | 0.110 |
Why?
| | Risk Factors | 4 | 2024 | 10482 | 0.110 |
Why?
| | Prognosis | 2 | 2022 | 4080 | 0.110 |
Why?
| | Internship and Residency | 1 | 2024 | 1240 | 0.100 |
Why?
| | United States | 5 | 2024 | 15310 | 0.100 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 619 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 805 | 0.100 |
Why?
| | Critical Illness | 1 | 2019 | 837 | 0.100 |
Why?
| | Risk Assessment | 2 | 2021 | 3508 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1077 | 0.100 |
Why?
| | Depression | 1 | 2022 | 1508 | 0.090 |
Why?
| | Blood Glucose | 1 | 2022 | 2278 | 0.090 |
Why?
| | Wounds and Injuries | 1 | 2019 | 897 | 0.090 |
Why?
| | Adult | 8 | 2024 | 39391 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2193 | 0.080 |
Why?
| | Child | 4 | 2024 | 22414 | 0.080 |
Why?
| | Male | 9 | 2023 | 70179 | 0.080 |
Why?
| | Middle Aged | 6 | 2024 | 34647 | 0.070 |
Why?
| | Infant | 1 | 2022 | 9843 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2024 | 11181 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 2093 | 0.060 |
Why?
| | Lung | 1 | 2019 | 4137 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2075 | 0.050 |
Why?
| | Eggs | 1 | 2024 | 29 | 0.050 |
Why?
| | Organizational Policy | 1 | 2024 | 84 | 0.050 |
Why?
| | Cooking | 1 | 2024 | 66 | 0.050 |
Why?
| | Research Design | 2 | 2021 | 1146 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 67 | 0.050 |
Why?
| | Milk | 1 | 2024 | 123 | 0.050 |
Why?
| | Incidence | 2 | 2021 | 2806 | 0.050 |
Why?
| | Infertility, Female | 1 | 2024 | 108 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 116 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 127 | 0.050 |
Why?
| | Qualitative Research | 2 | 2021 | 1547 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2024 | 376 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2022 | 215 | 0.040 |
Why?
| | Allergens | 1 | 2024 | 401 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 185 | 0.040 |
Why?
| | Technology | 1 | 2021 | 94 | 0.040 |
Why?
| | Uncertainty | 1 | 2021 | 139 | 0.040 |
Why?
| | Canada | 1 | 2021 | 429 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 239 | 0.040 |
Why?
| | Late Onset Disorders | 1 | 2019 | 2 | 0.040 |
Why?
| | Vulnerable Populations | 1 | 2021 | 170 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 534 | 0.040 |
Why?
| | Triage | 1 | 2022 | 246 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 450 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 432 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 833 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 124 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2023 | 498 | 0.040 |
Why?
| | Stroke Volume | 1 | 2021 | 590 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 22130 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 516 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 337 | 0.030 |
Why?
| | Health Education | 1 | 2021 | 364 | 0.030 |
Why?
| | Health Information Management | 1 | 2016 | 7 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 188 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 618 | 0.030 |
Why?
| | Lepidoptera | 1 | 1975 | 10 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 175 | 0.030 |
Why?
| | Aminopeptidases | 1 | 1975 | 22 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 378 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1482 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1820 | 0.030 |
Why?
| | Moths | 1 | 1975 | 52 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 203 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 738 | 0.030 |
Why?
| | Marijuana Abuse | 1 | 2016 | 231 | 0.030 |
Why?
| | Young Adult | 2 | 2023 | 13749 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 16374 | 0.030 |
Why?
| | Animals | 4 | 2024 | 37749 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1502 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2938 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2902 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 7092 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 3008 | 0.020 |
Why?
| | Biomedical Research | 1 | 2016 | 708 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3597 | 0.020 |
Why?
| | Nucleic Acid Denaturation | 1 | 1976 | 32 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5974 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4629 | 0.020 |
Why?
| | Digitoxin | 1 | 1975 | 4 | 0.010 |
Why?
| | Sulfates | 1 | 1976 | 49 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 1975 | 81 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1976 | 557 | 0.010 |
Why?
| | DNA | 1 | 1976 | 1444 | 0.010 |
Why?
| | Mercury | 1 | 1975 | 40 | 0.010 |
Why?
| | Molecular Weight | 1 | 1975 | 329 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1975 | 336 | 0.010 |
Why?
| | Copper | 1 | 1975 | 115 | 0.010 |
Why?
| | Larva | 1 | 1975 | 238 | 0.010 |
Why?
| | Oligopeptides | 1 | 1975 | 275 | 0.010 |
Why?
| | Zinc | 1 | 1975 | 299 | 0.010 |
Why?
| | Kinetics | 1 | 1975 | 1655 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 497 | 0.010 |
Why?
| | Chemistry | 1 | 1976 | 44 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1976 | 82 | 0.000 |
Why?
| | Digitoxigenin | 1 | 1975 | 2 | 0.000 |
Why?
| | Chromatography, Thin Layer | 1 | 1975 | 27 | 0.000 |
Why?
| | Hydroxylation | 1 | 1975 | 45 | 0.000 |
Why?
| | NADP | 1 | 1975 | 53 | 0.000 |
Why?
| | Solutions | 1 | 1976 | 168 | 0.000 |
Why?
| | Thymus Gland | 1 | 1976 | 319 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1975 | 1094 | 0.000 |
Why?
| | Cattle | 1 | 1976 | 998 | 0.000 |
Why?
| | Rats | 1 | 1975 | 5637 | 0.000 |
Why?
| | Time Factors | 1 | 1975 | 6966 | 0.000 |
Why?
|
|
DeSanto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|